Quint Media Inc Share Price Other OTC
Equities
US74874T1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 0.57 47.39 | Sales 2023 | 0.61 50.64 | Capitalization | 5.54M 462M |
---|---|---|---|---|---|
Net income 2022 | -12M -1B | Net income 2023 | -30M -2.5B | EV / Sales 2022 | 4,49,15,754 x |
Net Debt 2022 | 3.98M 332M | Net Debt 2023 | 18.76M 1.57B | EV / Sales 2023 | 4,00,45,900 x |
P/E ratio 2022 |
-1.59
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.39% |
Managers | Title | Age | Since |
---|---|---|---|
Faith Zaslavsky
CEO | Chief Executive Officer | 49 | 05/22/05 |
Director of Finance/CFO | 43 | 01/09/01 | |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 18/20/18 |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 01/18/01 |
Director of Finance/CFO | 43 | 01/09/01 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |